This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kwan, H
Right arrow Articles by Varmus, H E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kwan, H
Right arrow Articles by Varmus, H E

 Previous Article  |  Next Article 

Mol Cell Biol. 1992 January; 12(1): 147-154

Transgenes expressing the Wnt-1 and int-2 proto-oncogenes cooperate during mammary carcinogenesis in doubly transgenic mice.

H Kwan, V Pecenka, A Tsukamoto, T G Parslow, R Guzman, T P Lin, W J Muller, F S Lee, P Leder and H E Varmus

Department of Microbiology and Immunology, University of California, San Francisco 94143.

ABSTRACT

The Wnt-1 and int-2 proto-oncogenes are transcriptionally activated by mouse mammary tumor virus insertion mutations in virus-induced tumors and encode secretory glycoproteins. To determine whether these two genes can cooperate during carcinogenesis, we have crossed two previously characterized lines of transgenic mice to obtain bitransgenic animals carrying both Wnt-1 and int-2 transgenes under the control of the mouse mammary tumor virus long terminal repeat. Mammary carcinomas appear earlier and with higher frequency in the bitransgenic animals, especially the males, than in either parental line. Nearly all bitransgenic males develop mammary neoplasms within 8 months of birth, whereas only 15% of Wnt-1 transgenic males and none of the int-2 transgenic males have tumors. In virgin bitransgenic females, tumors occur approximately 2 months earlier than in their Wnt-1 transgenic siblings; int-2 transgenic females rarely exhibit tumors. Preneoplastic glands from the bitransgenic animals of either sex demonstrate pronounced epithelial hyperplasia similar to that seen in Wnt-1 transgenic virgin females and males, and both transgenes are expressed in the hyperplastic glands and mammary tumors. RNA from the int-2 transgene is more abundant in mammary glands from bitransgenic animals than from int-2 transgenic animals; the increase is associated with high levels of RNA specific for keratin genes 14 and 18, suggesting that Wnt-1-induced epithelial hyperplasia is responsible for the observed increase in expression of the int-2 transgene.

Mol Cell Biol. 1992 January; 12(1): 147-154




This article has been cited by other articles:

  • Labbe, E., Lock, L., Letamendia, A., Gorska, A. E., Gryfe, R., Gallinger, S., Moses, H. L., Attisano, L. (2007). Transcriptional Cooperation between the Transforming Growth Factor-{beta} and Wnt Pathways in Mammary and Intestinal Tumorigenesis. Cancer Res. 67: 75-84 [Abstract] [Full Text]  
  • Lowther, W., Wiley, K., Smith, G. H., Callahan, R. (2005). A New Common Integration Site, Int7, for the Mouse Mammary Tumor Virus in Mouse Mammary Tumors Identifies a Gene Whose Product Has Furin-Like and Thrombospondin-Like Sequences. J. Virol. 79: 10093-10096 [Abstract] [Full Text]  
  • Gorska, A. E., Jensen, R. A., Shyr, Y., Aakre, M. E., Bhowmick, N. A., Moses, H. L. (2003). Transgenic Mice Expressing a Dominant-Negative Mutant Type II Transforming Growth Factor-{beta} Receptor Exhibit Impaired Mammary Development and Enhanced Mammary Tumor Formation. Am. J. Pathol. 163: 1539-1549 [Abstract] [Full Text]  
  • Chatterjee, G., Rosner, A., Han, Y., Zelazny, E. T., Li, B., Cardiff, R. D., Perkins, A. S. (2002). Acceleration of Mouse Mammary Tumor Virus-Induced Murine Mammary Tumorigenesis by a p53172H Transgene: Influence of FVB Background on Tumor Latency and Identification of Novel Sites of Proviral Insertion. Am. J. Pathol. 161: 2241-2253 [Abstract] [Full Text]  
  • Rosner, A., Miyoshi, K., Landesman-Bollag, E., Xu, X., Seldin, D. C., Moser, A. R., MacLeod, C. L., Shyamala, G., Gillgrass, A. E., Cardiff, R. D. (2002). Pathway Pathology : Histological Differences Between ErbB/Ras and Wnt Pathway Transgenic Mammary Tumors. Am. J. Pathol. 161: 1087-1097 [Abstract] [Full Text]  
  • Blackshear, P. E. (2001). Genetically Engineered Rodent Models of Mammary Gland Carcinogenesis: An Overview. Toxicol Pathol 29: 105-116 [Abstract]  
  • Kase, S., Sugio, K., Yamazaki, K., Okamoto, T., Yano, T., Sugimachi, K. (2000). Expression of E-cadherin and {beta}-Catenin in Human Non-Small Cell Lung Cancer and the Clinical Significance. Clin. Cancer Res. 6: 4789-4796 [Abstract] [Full Text]  
  • ALBANESE, C., REUTENS, A. T., BOUZAHZAH, B., FU, M., D’AMICO, M., LINK, T., NICHOLSON, R., DEPINHO, R. A., PESTELL, R. G. (2000). Sustained mammary gland-directed, ponasterone A-inducible expression in transgenic mice. FASEB J. 14: 877-884 [Abstract] [Full Text]  
  • Holland, E. C. (2000). A Mouse Model for Glioma: Biology, Pathology, and Therapeutic Opportunities. Toxicol Pathol 28: 171-177 [Abstract]  
  • Pötter, E., Bergwitz, C., Brabant, G. (1999). The Cadherin-Catenin System: Implications for Growth and Differentiation of Endocrine Tissues. Endocr. Rev. 20: 207-239 [Abstract] [Full Text]  
  • Bocchinfuso, W. P., Hively, W. P., Couse, J. F., Varmus, H. E., Korach, K. S. (1999). A Mouse Mammary Tumor Virus-Wnt-1 Transgene Induces Mammary Gland Hyperplasia and Tumorigenesis in Mice Lacking Estrogen Receptor-{{alpha}}. Cancer Res. 59: 1869-1876 [Abstract] [Full Text]  
  • Holland, E. C., Hively, W. P., DePinho, R. A., Varmus, H. E. (1998). A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice. Genes Dev. 12: 3675-3685 [Abstract] [Full Text]  
  • Holland, E. C., Varmus, H. E. (1998). Basic fibroblast growth factor induces cell migration and proliferation after glia-specific gene transfer in mice. Proc. Natl. Acad. Sci. USA 95: 1218-1223 [Abstract] [Full Text]  
  • Donehower, L A, Godley, L A, Aldaz, C M, Pyle, R, Shi, Y P, Pinkel, D, Gray, J, Bradley, A, Medina, D, Varmus, H E (1995). Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability.. Genes Dev. 9: 882-895 [Abstract]  
  • Taylor, I. C. A., Roy, S., Yaswen, P., Stampfer, M. R., Varmus, H. E. (1995). Mouse Mammary Tumors Express Elevated Levels of RNA Encoding the Murine Homolog of SKY, a Putative Receptor Tyrosine Kinase. J. Biol. Chem. 270: 6872-6880 [Abstract] [Full Text]  
  • Echelard, Y, Vassileva, G, McMahon, A. (1994). Cis-acting regulatory sequences governing Wnt-1 expression in the developing mouse CNS. Development 120: 2213-2224 [Abstract]  
  • Varmus, H.E., Godley, L.A., Roy, S., Taylor, I.C.A., Yuschenkoff, L., Shi, Y.-P., Pinkel, D., Gray, J., Pyle, R., Aldaz, C.M., Bradley, A., Medina, D., Donehower, L.A. (1994). Defining the Steps in a Multistep Mouse Model for Mammary Carcinogenesis. Cold Spring Harb Symp Quant Biol 59: 491-499 [Abstract]  
  • D'Amico, M., Hulit, J., Amanatullah, D. F., Zafonte, B. T., Albanese, C., Bouzahzah, B., Fu, M., Augenlicht, L. H., Donehower, L. A., Takemaru, K.-I., Moon, R. T., Davis, R., Lisanti, M. P., Shtutman, M., Zhurinsky, J., Ben-Ze'ev, A., Troussard, A. A., Dedhar, S., Pestell, R. G. (2000). The Integrin-linked Kinase Regulates the Cyclin D1 Gene through Glycogen Synthase Kinase 3beta and cAMP-responsive Element-binding Protein-dependent Pathways. J. Biol. Chem. 275: 32649-32657 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»